Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic disorders such as inflammatory diseases
3.2.1.2 Surge in demand for CRP testing for diagnosis and management of chronic diseases
3.2.1.3 Advances in technology
3.2.1.4 Growing demand for direct-to-home testing services
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of standardization
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Reimbursement scenario
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Kits and reagents
Chapter 6 Market Estimates and Forecast, By Assay Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Chemiluminescence immunoassay (CLIA)
6.3 Enzyme-linked immunosorbent assay (ELISA)
6.4 Immunoturbidimetric assay
6.5 Other assay types
Chapter 7 Market Estimates and Forecast, By Detection Range, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 High-sensitivity CRP (hs-CRP)
7.3 Standard CRP
Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Cardiovascular diseases
8.3 Infectious diseases
8.4 Chronic inflammatory diseases
8.5 Other applications
Chapter 9 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals and clinics
9.3 Diagnostic laboratories
9.4 Other end-users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Abbott
11.2 Agilent technologies
11.3 Aidian
11.4 Boditech Med, Inc.
11.5 Creative diagnostics
11.6 CTK Biotech
11.7 Danaher
11.8 DxGen Corp
11.9 F. Hoffmann-La Roche Ltd.
11.10 Getein Biotech, Inc.
11.11 Goldsite diagnostics
11.12 HORIBA, Ltd
11.13 Laboratory Corporation of American Holding
11.14 LumiraDX
11.15 Merck KGaA
11.16 Optibio co., Ltd
11.17 Randox Laboratories Ltd.
11.18 Siemens Healthineers AG
